Emerald Health Aims to Revolutionize Pain Management

Marc Davis is the the editor of www.CannabisCapitalist.ca, a digital resource for investors who follow Canada’s top-flight medical marijuana stocks.

In this interview, Marc talks to Bin Huang, PhD, MBA, who is the President and CEO of Emerald Health Therapeutics (TSX.V: EMH).

Her company is a pioneer in the race to develop pharmaceutical-grade medicinal formulas from the cannabis plant to address chronic pain and sleep disorders. To this end, the company has a strong science-driven focus.

Click here to read the entire article

 

Article by: Marc Davis on Stockhouse.

2017-06-02T15:55:47+00:00 March 27th, 2017|Media|